Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
High immunity cows soon available
New technology breakthrough identifies level of immunity

Sires with a higher natural level of disease resistance will soon be available for farmers to buy, thanks to the latest technology.

Cattle genetics suppliers, Semex, are to sell sires identified as having high immunity - a trait that can be passed on to their offspring in the same way as other inherited traits - under a new brand, immunity+.

Research led by Dr Bonnie Mallard, of the University of Guelph, Canada, found that cows with High Immune Response (HIR) are two to four times less likely to contract diseases than those cows with Low Immune Response (LIR).

The HIR technology identified cows with levels of immune response to diseases such as mastitis, metritis, ketosis, retained placenta and Johne's disease. Those cows with high immunity have a 25 per cent chance of passing the trait on to their offspring.

The company says the new technology "marks a significant breakthrough in improving disease resistance in cattle which will reduce the use of remedial medication".

Managing Director Gordon Miller added: "Trials have shown that using these high immunity sires can significantly reduce the percentage of disease in a herd, which we estimate will be worth about £50 per cow."

HIR testing takes place over two weeks, involving blood samples and skin thickness tests, and the animals are immunised in a similar way to a vaccination that stimulates the immune system.

Sires only need to be tested once in their lifetime to determine genetic immunity levels.

Due to the amount of money invested into the research, the test will be unique to Semex for the next ten years. The first two Immunity+ sires to be marketed are R-E-W Seaver and Charpentier LFG Spectrum. 

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.